Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
, Computer Science, Engineering and Molecular Medicine. Applicants must hold, or anticipate receiving before starting at EMBL, a university degree that would formally qualify them to enter a PhD or equivalent
-
. This includes supporting parents . About EMBL Australia Australia is the first Associate Member of the European Molecular Biology Laboratory (EMBL). EMBL is an international research organisation that fosters
-
European Molecular Biology Laboratory (EMBL) | Brandenburg an der Havel, Brandenburg | Germany | 2 months ago
Are you ready to lead groundbreaking research in AI for Biology? Join us at EMBL! We are seeking a visionary scientist to establish their own independent research group bridging innovations in
-
Engineering (MIME), the Biomedical Discovery Institute (BDI), and CSIRO. As an EMBL Australia Group Leader you will also be deeply embedded within the EMBL Australia Partner Laboratory Network. Key
-
. About EMBL Australia Australia is the first Associate Member of the European Molecular Biology Laboratory (EMBL). EMBL is an international research organisation that fosters excellence by providing a
-
technological developments within their field of activity - Contribute to the dissemination and promotion of results through oral presentations and publications Located on the Grenoble Science Park (ESRF/ILL/EMBL
-
The Department of Molecular Biology and Genetics and the Danish Research Institute of Translational Neuroscience (DANDRITE, Nordic-EMBL partnership in molecular medicine) at Aarhus University
-
research environment, with the European Molecular Biology Laboratory (EMBL), German Cancer Research Center (DKFZ), Heidelberg Institute for Theoretical Studies (HITS), and Max Planck Institute for Medical
-
arkitekter 14th September 2026 Languages English English English Join Norway’s flagship centre for systems-level molecular medicine Group Leader in Computational Biology Apply for this job See advertisement
-
research environment, with the European Molecular Biology Laboratory (EMBL), German Cancer Research Center (DKFZ), Heidelberg Institute for Theoretical Studies (HITS), and Max Planck Institute for Medical